208 related articles for article (PubMed ID: 16520989)
41. Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells.
Barna G; Sebestyén A; Weischede S; Peták I; Mihalik R; Formelli F; Kopper L
Anticancer Res; 2005; 25(6B):4179-85. PubMed ID: 16309214
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells.
Tiwari M; Bajpai VK; Sahasrabuddhe AA; Kumar A; Sinha RA; Behari S; Godbole MM
Carcinogenesis; 2008 Mar; 29(3):600-9. PubMed ID: 18174255
[TBL] [Abstract][Full Text] [Related]
43. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
Simeone AM; Deng CX; Kelloff GJ; Steele VE; Johnson MM; Tari AM
Carcinogenesis; 2005 May; 26(5):1000-7. PubMed ID: 15695235
[TBL] [Abstract][Full Text] [Related]
44. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
45. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
Lewis KC; Hochadel JF
Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240
[TBL] [Abstract][Full Text] [Related]
46. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
Han HS; Kwon YJ; Park SH; Kim EJ; Rho YS; Sin HS; Um SJ
Int J Cancer; 2004 Mar; 109(1):58-64. PubMed ID: 14735468
[TBL] [Abstract][Full Text] [Related]
47. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
[TBL] [Abstract][Full Text] [Related]
48. The chemopreventive agents 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas.
Broaddus RR; Xie S; Hsu CJ; Wang J; Zhang S; Zou C
Am J Obstet Gynecol; 2004 Mar; 190(3):686-92. PubMed ID: 15042000
[TBL] [Abstract][Full Text] [Related]
49. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
[TBL] [Abstract][Full Text] [Related]
50. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines.
Holmes WF; Soprano DR; Soprano KJ
J Cell Physiol; 2004 Jun; 199(3):317-29. PubMed ID: 15095280
[TBL] [Abstract][Full Text] [Related]
51. Carnosol delays chemotherapy-induced DNA fragmentation and morphological changes associated with apoptosis in leukemic cells.
Zunino SJ; Storms DH
Nutr Cancer; 2009; 61(1):94-102. PubMed ID: 19116879
[TBL] [Abstract][Full Text] [Related]
52. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
53. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
[TBL] [Abstract][Full Text] [Related]
54. N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species.
Goto H; Takahashi H; Fujii H; Ikuta K; Yokota S
Int J Hematol; 2003 Oct; 78(3):219-25. PubMed ID: 14604280
[TBL] [Abstract][Full Text] [Related]
55. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
[TBL] [Abstract][Full Text] [Related]
56. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
Takahashi N; Sausville EA; Breitman TR
Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
[TBL] [Abstract][Full Text] [Related]
57. CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner.
Huang J; Yang M; Liu H; Jin J
Food Chem Toxicol; 2009 Jan; 47(1):40-9. PubMed ID: 18761050
[TBL] [Abstract][Full Text] [Related]
58. Involvement of Rac in fenretinide-induced apoptosis.
Kadara H; Tahara E; Kim HJ; Lotan D; Myers J; Lotan R
Cancer Res; 2008 Jun; 68(11):4416-23. PubMed ID: 18519704
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.
Gouazé-Andersson V; Flowers M; Karimi R; Fabriás G; Delgado A; Casas J; Cabot MC
Prostate; 2011 Jul; 71(10):1064-73. PubMed ID: 21557271
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress.
Tiwari M; Kumar A; Sinha RA; Shrivastava A; Balapure AK; Sharma R; Bajpai VK; Mitra K; Babu S; Godbole MM
Carcinogenesis; 2006 Oct; 27(10):2047-58. PubMed ID: 16675469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]